On February 16, 2021 Artios Pharma ("Artios"), a leading DNA Damage Response (DDR) company developing a broad pipeline of precision medicines for the treatment of cancer, reported it is scheduled to participate in the following upcoming virtual conferences (Press release, Artios Pharma, FEB 16, 2021, View Source [SID1234578233]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

LifeSci Partners Precision Oncology Day

17 February 2021

Niall Martin, Chief Executive Officer at Artios Pharma will present an overview of the company at 10.00am ET.

A replay of the presentation will be available to view after the conference on the Artios website.

10th Annual SVB Leerink Virtual Global Healthcare Conference

22 -26 February 2021

Niall Martin, Chief Executive Officer, Tania Dimitrova, Chief Business Officer, and Abid Ansari, Chief Financial Officer will participate in 1 x 1 meetings.

Barclays Healthcare Conference 2021

9 -11 March 2021

Tania Dimitrova, Chief Business Officer at Artios Pharma will present an overview of the company at 9.45am ET on Tuesday 9 March.

Niall Martin, Chief Executive Officer, Tania Dimitrova, Chief Business Officer, and Abid Ansari, Chief Financial Officer will participate in 1:1 meetings.

A replay of the presentation will be available to view after the conference on the Artios website.